“…The development of antibody-based technologies to detect DON is advancing rapidly and has resulted in many novel technologies being applied. These have included fluorescence polarisation immunoassay (Lippolis, Pascale, & Visconti, 2006;Maragos & Plattner 2002), surface plasmon-based immunoassays (Kadota et al, 2010;Schnerr, Vogel, & Niessen, 2002;Tü dos, Lucas-van den Bos, & Stigter, 2003), array-based devices (Ngundi et al, 2006), flow cytometry (Peters, BienenmannPloum, de Rijk, & Haasnoot, 2011) and biolayer interferometry (Maragos, 2011). In addition, there have been recent advances in the use of antibodies in novel cleanup and isolation technologies including immuno-ultrafiltration, sol-gel immunoaffinity columns and polymer-based solid phase extraction (Bö hm, Cichna-Markl, BrennStruckhofova, & Razzazi-Fazeli, 2008;Brenn-Stuckhofova, Fü reder, Cichna-Markl, & Razzazi-Fazeli, 2009;Pascale et al, 2008).…”